{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:03:13Z","timestamp":1779296593816,"version":"3.51.4"},"reference-count":47,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2015,11,2]]},"DOI":"10.1517\/14712598.2015.1083552","type":"journal-article","created":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T14:47:58Z","timestamp":1442069278000},"page":"1633-1646","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":20,"title":["Biosimilar monoclonal antibodies: the scientific basis for extrapolation"],"prefix":"10.1517","volume":"15","author":[{"given":"Huub","family":"Schellekens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Lietzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freddy","family":"Faccin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaap","family":"Venema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,9,12]]},"reference":[{"key":"CIT0001","volume-title":"Guidance for industry scientific considerations in demonstrating biosimilarity to a reference product","author":"U.S. Department of Health and Human Services, Food and Drug Administration","year":"2012"},{"key":"CIT0002","volume-title":"Guideline on similar biological medicinal products (Revision)","author":"European Medicines Agency","year":"2014"},{"key":"CIT0003","volume-title":"Guidance for sponsors: information and submission requirements for subsequent entry biologics (SEBs)","author":"Health Canada","year":"2010"},{"key":"CIT0004","volume-title":"Evaluation of biosimilars","author":"Therapeutic Goods Administration","year":"2013"},{"key":"CIT0005","volume-title":"Guidelines on evaluation of similar biotherapeutic products (SBPs)","author":"World Health Organization Expert Committee on Biological Standardization","year":"2009"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-013-9534-y"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202715"},{"key":"CIT0008","volume-title":"Guideline on similar biological medicinal products containing monoclonal antibodies - non-clinical and clinical issues","author":"European Medicines Agency","year":"2012"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.339"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200721060-00003"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.686902"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011931"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/BS.S20577","volume":"1","author":"Chow S-C","year":"2011","journal-title":"Biosimilars"},{"key":"CIT0015","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.1177\/089686080702702s52","volume":"27","author":"Locatelli F","year":"2007","journal-title":"Perit Dial Int"},{"key":"CIT0016","volume-title":"Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues","author":"European Medicines Agency","year":"2006"},{"key":"CIT0017","volume-title":"Guidance on similar medicinal products containing recombinant granulocyte-colony stimulating factor","author":"European Medicines Agency","year":"2006"},{"key":"CIT0018","volume-title":"Guideline on non-clinical and clinical development of similar biological medicinal products containing recombinant erythropoietins (Revision)","author":"European Medicines Agency","year":"2010"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2014.05.005"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.3.3.15599"},{"key":"CIT0022","volume-title":"EPAR summary for the public: Inflectra","author":"European Medicines Agency","year":"2013"},{"key":"CIT0023","volume-title":"Full Prescribing Information","author":"Remicade\u00ae (infliximab)","year":"2013"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203090"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203091"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e318281333b"},{"key":"CIT0028","volume-title":"Assessment report: Remsima","author":"European Medicines Agency","year":"2013"},{"key":"CIT0029","volume-title":"Guidance for industry Q8(R2) pharmaceutical development","author":"U.S. Department of Health and Human Services, Food and Drug Administration","year":"2009"},{"key":"CIT0030","first-page":"34","volume":"27","author":"Rathore AS","year":"2014","journal-title":"BioPharm International"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.2174\/138920021503140412212905"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.2165\/11530550-000000000-00000"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203198"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1002\/art.22214"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00238-1"},{"key":"CIT0036","volume-title":"Full Prescribing Information","author":"Humira\u00ae (adalimumab)","year":"2013"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e328329ed8b"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199710093371502"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08512-4"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199905063401804"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030815"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050516"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011303432202"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1002\/art.20568"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1002\/art.20852"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1002\/art.20967"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.032268"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67566-6"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.07.017"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.02.021"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14712598.2015.1083552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T18:56:11Z","timestamp":1653159371000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14712598.2015.1083552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,12]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,7,15]]},"published-print":{"date-parts":[[2015,11,2]]}},"alternative-id":["10.1517\/14712598.2015.1083552"],"URL":"https:\/\/doi.org\/10.1517\/14712598.2015.1083552","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}